Research and Training Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on August 7, 2019

Feed last updated: December 05 2019 7:50 pm
Title FOA Number Organization Release Date Expiration Date Purpose Search Terms
Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional) RFA-NS-18-046 NINDS Sep 19 2018 Mar 13 2020 The overarching purpose of this Funding Opportunity Announcement (FOA) is to promote the validation of strong candidate biomarkers and endpoints for pain that can be used to facilitate the development of non-opioid pain therapeutics from discovery through Phase II clinical trials. Specifically, the focus of this FOA is on advanced analytical and clinical validation of pain biomarkers, biomarker signatures, and/or endpoints using retrospective and/or prospective methods. It is assumed that: 1) a candidate biomarker has already been identified, 2) assay technology has already been developed, and 3) a working hypothesis regarding Context of Use is in place. Research supported by this FOA will ultimately demonstrate that biomarker or endpoint change is reliably correlated with variables such as clinical outcome, pathophysiologic subsets of pain, therapeutic target engagement or response to a pain therapeutic; in addition, biomarker response will demonstrate specificity to the pain condition or therapeutic as demonstrated at multiple clinical sites. The goal of this FOA is to facilitate the advancement of robust and reliable biomarkers, biomarker signatures and endpoints of pain to application in clinical trials (Phase II clinical trials and beyond) and in the spectrum of clinical practice.
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Cl PAR-18-701 NIMH Mar 05 2018 May 19 2020 This Funding Opportunity Announcement (FOA) invites applications for centers to support transdisciplinary teams of clinical and mental health services researchers, behavioral scientists, social scientists, health information and communications technologists, health systems engineers, decision scientists, and mental health stakeholders (e.g., service users, family members, clinicians, payers) to engage in high-impact studies that will significantly advance clinical practice and generate knowledge that will fuel transformation of mental health care in the United States. Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers will support the rapid development, testing, and refinement of novel and integrative approaches for (1) optimizing the effectiveness of therapeutic or preventive interventions for mental disorders within well-defined target populations; (2) organizing and delivering optimized mental health services within real world treatment settings; and (3) continuously improving the quality, impact, and durability of optimized interventions and service delivery within diverse care systems. The ALACRITY Centers program is intended to support research that demonstrates an extraordinary level of synergy across disciplines and has a high potential for increasing the public health impact of existing and emerging mental health interventions and service delivery strategies. The Centers are intended for transdisciplinary projects that could not be achieved using standard research project grant mechanisms. The ALACRITY Centers program is also expected to provide opportunities for graduate students, postdoctoral researchers, and new investigators to participate in transdisciplinary, T2 translational mental health research.
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) PAR-18-714 NIGMS Mar 14 2018 May 08 2021 The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at these applicant institutions. Eligible institutions must award baccalaureate science degrees, and have received less than 6 million dollars per year of NIH support (total costs) in 4 of the last 7 fiscal years.
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required) PAR-19-133 NICHD Dec 21 2018 Jan 08 2021 The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences for undergraduate students and enhancing the research environment at these applicant institutions. Eligible institutions must award baccalaureate science degrees and have received less than 6 million dollars per year of NIH support (total costs) in 4 of the last 7 fiscal years. This funding opportunity announcement (FOA) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. Minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm.
NOT-RM-17-010 Roadmap Mar 24 2017 N/A Notice Expiration RFA-ES-16-011 BD2K Research Education Curriculum Development: Data Science Overview Biomedical Scientists R25)" Notice Number: NOT-RM-17-010 Key Dates Release Date:   March 24, 2017 Related Announcements RFA-ES-16-011 Issued National Institute Environmental Health Sciences NIEHS) Office Strategic Coordination Common Fund) Purpose Notice informs potential applicants the cancellation the December 1, 2017 receipt date for RFA-ES-16-011, BD2K Research Education Curriculum Development: Data Science Overview Biomedical Scientists R25). Additional applications not accepted BD2K FY 2017. amount diversity data generated NIH-funded research programs continues grow rapidly, necessitating safe, scalable storage solutions, new analytic approaches, an adaptable workforce. this unprecedented revolution biological information unfolds NIH looks the future data science, needs ensure researchers the ability make meaningful of increasingly massive biomedical data resource.  will critical NIH identify implement new strategies improve data discoverability, utility, sustainability, including moving large data sets the cloud making adherent FAIR Principles – Findable, Accessible, Interoperable, Reusable.  Success meeting challenge require major infusion resources. Patricia Flatley Brennan, Director the National Library Medicine NLM), her role interim Associate Director Data Science, work all NIH’s 27 Institutes Centers develop strategies improve data discoverability, utility, sustainability the biomedical research community. Previously issued BD2K funding opportunities being canceled that new funding opportunities be issued support implementation the new strategies. Currently reads:  Posted Date August 10, 2016 Open Date Earliest Submission Date) November 7, 2016 Letter Intent Due Date(s) Applicable Application Due Date(s) December 7, 2016; December 1, 2017, 5:00 PM local time applicant organization. types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) Applicable Scientific Merit Review March 2017; nbsp;March 2018 Advisory Council Review 2017; 2018 Earliest Start Date September 2017; September 2018 Expiration Date December 2, 2017 Due Dates E.O. 12372 Applicable Modified read: Posted Date August 10, 2016 Open Date Earliest Submission Date) November 7, 2016 Letter Intent Due Date(s) Applicable Application Due Date(s) December 7, 2016, 5:00 PM local time applicant organization. types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) Applicable Scientific Merit Review March 2017 Advisory Council Review 2017 Earliest Start Date September 2017 Expiration Date December 8, 2016 Due Dates E.O. 12372 Applicable Details program changes been announced the program's current website: https://commonfund.nih.gov/bd2k/index Inquiries Please direct inquiries to: Carol Shreffler, Ph.D. National Institute Environmental Health Sciences NIEHS) Telephone:  919-541-1445 Email: bd2k_training@mail.nih.gov data science

Pages

XLS